Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAA-AQ HPA Axis Safety in Children with AR
NCT01154153Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2010
- Primary completion
- Oct 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in allergic rhinitis (AR), sponsored by Sanofi. Started Jun 2010; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01154153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01154153.